Metraipolis › archive › dc_70b554202caa

68Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A… — Europe PMC PMID:42562610

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42562610
DOI: 10.2967/jnumed.125.271529
License (as archived): solo-consultazione
Archived: 2026-10-07T17:06:18.552Z
SHA-256 of the archived text: 08417be05e5905d448ef7257b4010bdc6eb0c5f0353b8dc02fd3cf6e658665da
Stable URL of this page: https://metraipolis.com/documento/dc_70b554202caa

How to cite

68Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A… — Europe PMC PMID:42562610 — Europe PMC (en), https://europepmc.org/article/MED/42562610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70b554202caa (Metraipolis archive dc_70b554202caa, sha256 08417be05e5905d448ef7257b4010bdc6eb0c5f0353b8dc02fd3cf6e658665da)

BibTeX

@misc{dc70b554202caa,
  title = {68Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A… — Europe PMC PMID:42562610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42562610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70b554202caa; sha256 08417be05e5905d448ef7257b4010bdc6eb0c5f0353b8dc02fd3cf6e658665da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42562610. Agents can read the archived copy with the MCP tool read_document.